Non-Hormonal Treatment Strategies for Vasomotor Symptoms: A Critical Review

By Hall Elise   Frey Benicio N.   Soares Claudio N.  

Drugs, Vol. 71, Iss. 3, 2011-02 ,pp. : 287-304

Adis International

Access to resources Recommend Favorite

Tissue-Selective Estrogen Complex Bazedoxifene and Conjugated Estrogens for the Treatment of Menopausal Vasomotor Symptoms

By Stovall Dale W.   Tanner-Kurtz Kirby   Pinkerton JoAnn V.  

Drugs, Vol. 71, Iss. 13, 2011-09 ,pp. : 1649-1657

Adis International

Access to resources Recommend Favorite

Bazedoxifene + conjugated estrogens in HT for the prevention of osteoporosis and treatment of vasomotor symptoms associated with the menopause

By Tella Sri Harsha   Gallagher John Christopher  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 17, 2013-12 ,pp. : 2407-2420

Informa Healthcare

Access to resources Recommend Favorite

MF101: a multi-component botanical selective estrogen receptor beta modulator for the treatment of menopausal vasomotor symptoms

By Leitman Dale C   Christians Uwe  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 7, 2012-07 ,pp. : 1031-1042

Informa Healthcare

Access to resources Recommend Favorite

Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches

By  

Current Pharmaceutical Design, Vol. 22, Iss. 31, 2016-09 ,pp. : 4807-4822

Bentham Science Publishers

Access to resources Recommend Favorite